Health Services Research & Development

Veterans Crisis Line Badge
Go to the ORD website
Go to the QUERI website

Evidence Brief: Factors that Optimize Therapy with Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depressions

Click for list of published reports
Click for topic nomination form
Click for list of reports in progress

Subscribe to the
ESP Report RSS feed RSS feed icon
 Factors that Optimize Therapy with Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depressions: Evidence Brief
on the Relationship Between
Time Delay to Colonoscopy and Colorectal Cancer Outcomes

Investigators: Kim Peterson, MS; Ellen McCleery, MPH; Kallie Waldrip, MS; Mark Helfand, MD, MPH, MS

Evidence-based Synthesis Program (ESP) Coordinating Center, Portland VA Medical Center,
Portland, OR

Download PDF: Brief, Supplemental Materials

Background

Major depressive disorder is one of the most common mental disorders in the general and Veteran populations. The one-to two-thirds of MDD patients who do not respond to the first antidepressant prescribed, and the 15% to 33% who do not respond to multiple drugs are defined as having treatment-resistant depression (TRD). Repetitive transcranial magnetic stimulation (rTMS) is one of many possible options for treating TRD. It is supported by two FDA-cleared protocols and acceptable acute efficacy based on a recent Comparative Effectiveness Review conducted by the RTI-UNC EPC. This Evidence Brief synthesizes the literature on factors that optimize rTMS therapy in patients with TRD.

Key Question #1: Which patients have the best chance of success with rTMS?

Key Question #2: What are the optimal rTMS treatment protocols and parameters?

Key Question #3: What is known about the continuation and maintenance treatment in reponders?